Home Access and Saliva Diagnostics resolve lawsuits:
This article was originally published in Clinica
Executive Summary
US companies Saliva Diagnostic Systems and Home Access Health have dropped legal proceedings against each other and negotiated a new contract. SDS will re-license Omni-Sal, a saliva collection device, to Illinois-based Home Access for non-rapid testing (see Clinica No 690, p 15). Under the terms of the deal, SDS will continue to sell and license Omni-Sal for rapid testing, non-HIV applications and non-rapid testing other than in kits. The dispute was settled after both companies agreed to mediation hearings in August.